Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SelectX Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
SelectX Pharmaceuticals

SelectX Pharmaceuticals

Public

SelectX Pharmaceuticals Inc.: Boston-based biopharmaceutical firm developing advanced aminoglycoside therapeutics for unmet medical needs.

HQ
Boston, MA, US
Founded
2002
Overview
Compare
Fundraising
Employees

SelectX Pharmaceuticals Inc. is a Boston-based biopharmaceutical company focused on the discovery and development of advanced aminoglycoside therapeutics to address unmet medical needs. Their flagship product, SXP2523, is a next-generation aminoglycoside antibiotic targeting drug-resistant gram-negative hospital-acquired infections. The company is also working on an inhaled aminoglycoside antibiotic.

SelectX Pharmaceuticals has made significant strides in developing novel treatments for challenging infections, positioning itself as a key player in the biopharmaceutical industry. Their innovative approach to aminoglycoside therapeutics has garnered attention for its potential to combat drug-resistant bacteria, addressing a critical gap in current medical treatments.

SelectX Pharmaceuticals - Similar Companies

X-Biotix Therapeutics logo

X-Biotix Therapeutics

Nexcida Therapeutics logo

Nexcida Therapeutics

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Recida Therapeutics logo

Recida Therapeutics

Venatorx Pharmaceuticals logo

Venatorx Pharmaceuticals

venatorx.com

Spero Therapeutics logo

Spero Therapeutics

Xoc Pharmaceuticals logo

Xoc Pharmaceuticals

Summit Therapeutics logo

Summit Therapeutics

summittxinc.com

Atterx BioTherapeutics logo

Atterx BioTherapeutics

atterx.com

Cardeas Pharma logo

Cardeas Pharma

X4 Pharmaceuticals logo

X4 Pharmaceuticals

x4pharma.com

Synereca Pharmaceuticals logo

Synereca Pharmaceuticals

Endolytix logo

Endolytix

Bioxiness Pharmaceuticals logo

Bioxiness Pharmaceuticals

Revagenix logo

Revagenix

revagenix.com

SelectX Pharmaceuticals - Quick Facts

Who are SelectX Pharmaceuticals' competitors?

Companies similar to SelectX Pharmaceuticals include X-Biotix Therapeutics, Nexcida Therapeutics, Taxis Pharmaceuticals and Recida Therapeutics.

When was SelectX Pharmaceuticals founded?

SelectX Pharmaceuticals was founded in 2002.

Where is SelectX Pharmaceuticals' headquarters located?

SelectX Pharmaceuticals' headquarters is located in Boston, MA, US.

When was SelectX Pharmaceuticals' last funding round?

SelectX Pharmaceuticals' most recent funding round was for $8M (USD) in January 2004.

How much has SelectX Pharmaceuticals raised to-date?

As of Jan 23, 2004, SelectX Pharmaceuticals has raised a total of $8M (USD).

How many employees does SelectX Pharmaceuticals have?

SelectX Pharmaceuticals has 30 employees as of Feb 4, 2024.

SelectX Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibiotics
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified